Neuragenix

Neuragenix is a clinical-stage medical technology company focused on developing innovative, non-opioid treatments for chronic pain. The company's proprietary platform utilizes precision cryoneurolysis, a technique that applies controlled cold to peripheral nerves to interrupt pain signaling without causing permanent nerve damage. Neuragenix's lead applications target debilitating conditions such as knee osteoarthritis and chronic low back pain, aiming to provide long-lasting relief and improve functional outcomes for patients. By offering a targeted, minimally invasive alternative to systemic medications and surgery, Neuragenix seeks to address the significant unmet need in the global pain management market.